New Ultrasound Toothbrush Powers Brushing to a New Feeling of Clean

People concerned about oral health now have a new weapon against plaque. Ultreo, Inc. launched a revolutionary power toothbrush that combines ultrasound waveguide technology with precisely tuned sonic bristle action for a deep, gentle, long-lasting feeling of clean.

Ultreo’s proprietary technology uses ultrasound energy to transform normally inactive bubbles into pulsating bubbles for an incredible, long-lasting feeling of clean. Clinical studies prove that Ultreo can remove up to 95 percent of plaque from hard-to-reach areas in the first minute of brushing. We still recommend that you still brush for a full two minutes; these results should be excellent news for people who are in a hurry to get out of the house in the morning.

"The combined effect of ultrasound waveguide technology and precisely tuned sonic bristle action takes power brushing to new heights," said Dr. Christopher McInnes, principal scientist for Ultreo. "During a recent survey of users, nine out of ten people who used Ultreo thought their teeth felt smooth and clean after brushing and seven out of ten said they preferred Ultreo to the power toothbrush they were currently using."

To read the entire article, click here

New Antibiotic Prophylaxis Guidelines for Dental Patients from the American Heart Association

Recently, the American Heart Association updated its recommendations regarding dental patients and the necessity of pre-medicating with antibiotics to prevent infective endocarditis (IE) — an infection of the heart's inner lining or the heart valves — before visiting their dentist.

The new guidelines are based on a growing body of scientific evidence that shows the risks of taking precautionary antibiotics outweigh the benefits for most patients. Preventive antibiotics are not only unnecessary for most people but could result in allergic reactions or dangerous antibiotic resistance.

Patients at the greatest danger of bad out- comes from IE and for whom preventive antibiotics are recommended include those with (1) a history of having had IE (2) artificial heart valves (3) a completely repaired congenital heart defect with prosthetic material or device, whether placed by surgery or by catheter interventions, during the first six months after the procedure (4) any repaired congenital heart defect with residual defect at the site or adjacent to the site of a prosthetic patch or prosthetic device (5) certain specific, serious congenital (present from birth) heart conditions, including: unrepaired or incompletely repaired cyanotic congenital heart disease, including those with palliative shunts and conduits (6) a cardiac transplant which develops a problem in a heart valve.

To read the entire article, click here